phase readout
saveNCT04850118: A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
ACTIVE_NOT_RECRUITINGupdated 40m ago
community read0 votes
Sponsor: Beacon Therapeutics. Phase: PHASE2. Conditions: X-Linked Retinitis Pigmentosa
view source ↗
comments(0)
5-min edit window · permanent after that